Jan 7, 2025
In the dynamic world of investing, few events hold as much significance as new analyst coverage. When analysts…
ANALYST COVERAGE
Jan 7, 2025
William Blair initiated coverage on Elevation Oncology, Inc. ELEV, a cancer drug focus firm leveraging antibody-drug conjugate expertise…
Jan 7, 2025
Monday, January 6, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today’s…
Jan 6, 2025
Please enable JS and disable any ad blocker
Jan 6, 2025
January 6th 2025 at 1:04pm CST by Luke Adams Amazon Prime Video has reached a deal to hire…
Jan 6, 2025
In the last three months, 5 analysts have published ratings on Rollins ROL, offering a diverse range of…
Jan 6, 2025
Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating…
Jan 5, 2025
William Blair has initiated coverage on Denali Therapeutics Inc DNLI, a company focused on developing drugs for neurodegenerative…
Jan 3, 2025
On Friday, Citi analyst Alicia Yap maintained a Buy rating on JD.com, Inc. (NASDAQ:), with a steady price…
Jan 3, 2025
Market News and Data brought to you by Benzinga APIs © 2025 Benzinga.com. Benzinga does not provide investment…
Jan 2, 2025
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…
Dec 31, 2024
NewAmsterdam Pharma Company N.V.’s (NAMS:NASDAQ) drug obicetrapib is a “once-in-a-generation” drug for cardiovascular disease, an analyst wrote in…